Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis
Clinical trial NCT06723548 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06723548
- Sponsor
- First Affiliated Hospital of Wenzhou Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2025-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.